CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $19,000 | -50.0% | 3,175 | 0.0% | 0.01% | -52.6% |
| Q2 2019 | $38,000 | -81.5% | 3,175 | -81.3% | 0.02% | -81.6% |
| Q1 2019 | $205,000 | -8.5% | 16,987 | -5.0% | 0.10% | -21.4% |
| Q4 2018 | $224,000 | -11.5% | 17,887 | +4.9% | 0.13% | +24.8% |
| Q3 2018 | $253,000 | -9.3% | 17,055 | +2.9% | 0.10% | -13.2% |
| Q2 2018 | $279,000 | -26.6% | 16,582 | 0.0% | 0.12% | -28.4% |
| Q1 2018 | $380,000 | -7.5% | 16,582 | +4.4% | 0.17% | -8.2% |
| Q4 2017 | $411,000 | – | 15,882 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |